Tubal, Zyrahlyn M.

HRN: 28-24-58  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/03/2026
CEFUROXIME 250MG/5ML, 50ML SUSPENSION (BOT)
06/03/2026
06/07/2026
PO
2ml
BID
Measle Pneumonia
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: